1[1]D'Alonzo GE, Smolensky MH, Feldman S, et al.Bambuterolin the treatment of asthma[J]. Chest, 1995, 107(2) :406.
2[2]Rosenborg J, Larsson P, Nyberg L. Pharmacokinetics ofbambuterol during oral administration of plain tablets andsolution to healthy adults[J]. Br J Chin Pharmacol, 2000, 49(2) :199.
3[3]Handley DA, Scnanayake CH, Dutczak W, et al. Biologicalactions of formoterol isomers [ J ]. Pulm Pharmacol Ther,2002, 15(2): 135.
4[4]Ltvall J. The long and short ofβ2- agonists [ J]. PulmPharmacol Ther, 2002, 15(6) :497.
5[5]Settipane RA. Defining the effects of an inhaled eorticosteroidand long - acting beta - agonist on therapeutic targets [ J ].Allergy Asthma Proc, 2003,24(2) :85.
6[6]Barnes PJ. Scientific rationale for inhaled combination therapywith long- acting beta2- agonists and cortieosteroids [ J]. EurRespir J, 2002,19(1) :182.
